These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17472539)

  • 1. The management of psychosis in movement disorder patients.
    Chou KL; Borek LL; Friedman JH
    Expert Opin Pharmacother; 2007 May; 8(7):935-43. PubMed ID: 17472539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.
    Weintraub D; Hurtig HI
    Am J Psychiatry; 2007 Oct; 164(10):1491-8. PubMed ID: 17898337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
    Baskys A
    J Clin Psychiatry; 2004; 65 Suppl 11():16-22. PubMed ID: 15264967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine and risperidone treatment of psychosis in Parkinson's disease.
    Ellis T; Cudkowicz ME; Sexton PM; Growdon JH
    J Neuropsychiatry Clin Neurosci; 2000; 12(3):364-9. PubMed ID: 10956570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic management of psychosis in the elderly: a critical review.
    Hoeh N; Gyulai L; Weintraub D; Streim J
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):213-8. PubMed ID: 14653429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of clozapine in the treatment of movement disorders.
    Factor SA; Friedman JH
    Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotics in Parkinson-sensitive populations.
    Friedman JH; Fernandez HH
    J Geriatr Psychiatry Neurol; 2002; 15(3):156-70. PubMed ID: 12230086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of risperidone in psychosis associated with Huntington's disease.
    Madhusoodanan S; Brenner R
    Am J Geriatr Psychiatry; 1998; 6(4):347-9. PubMed ID: 9793585
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of psychosis in Parkinson's disease and dementia with Lewy Bodies: A review.
    Kyle K; Bronstein JM
    Parkinsonism Relat Disord; 2020 Jun; 75():55-62. PubMed ID: 32480308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychotic disorders in Parkinson's disease and dementia with Lewy bodies].
    Levin OS; Anikina MA; Shindriaeva NN; Zimniakova OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(6):82-8. PubMed ID: 21905342
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
    Drach LM
    Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.
    Fernandez HH; Trieschmann ME; Burke MA; Friedman JH
    J Clin Psychiatry; 2002 Jun; 63(6):513-5. PubMed ID: 12088163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychiatric problems in a motor disorder: psychosis in Huntington's disease].
    van der Weijde E; Schadé A
    Tijdschr Psychiatr; 2015; 57(3):215-9. PubMed ID: 25856745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with pimavanserin of Lewy body dementia related psychosis with previous clozapine intolerance - A case report.
    Nizon D; Abdel Ahad P; Chauviré V; Godier E; Gohier B; Kazour F
    Encephale; 2024 Jun; 50(3):358-359. PubMed ID: 38311485
    [No Abstract]   [Full Text] [Related]  

  • 16. Clozapine for the treatment of psychosis in Parkinson's disease: chart review of 49 patients.
    Wagner ML; Defilippi JL; Menza MA; Sage JI
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):276-80. PubMed ID: 8854298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.
    Broadstock M; Ballard C; Corbett A
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):779-86. PubMed ID: 25301532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of psychosis in Parkinson's disease: safety considerations.
    Fernandez HH; Trieschmann ME; Friedman JH
    Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating psychosis in movement disorder patients: a review.
    Borek LL; Friedman JH
    Expert Opin Pharmacother; 2014 Aug; 15(11):1553-64. PubMed ID: 24846479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosis Management in Lewy Body Dementia: A Comprehensive Clinical Approach.
    Badwal K; Kiliaki SA; Dugani SB; Pagali SR
    J Geriatr Psychiatry Neurol; 2022 May; 35(3):255-261. PubMed ID: 33461372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.